98834-08-3Relevant articles and documents
Piperazine ureido derivative, preparation method thereof and application of piperazine ureido derivative in medicine
-
, (2021/05/12)
The invention relates to piperazine ureido derivatives, a preparation method thereof and an application of the piperazine ureido derivatives in medicine. In particular, the invention relates to piperazine ureido derivatives as shown in a general formula (I), a preparation method thereof, pharmaceutical compositions containing the derivatives, and uses thereof as capsid protein inhibitors, especially in prevention and/or treatment of hepatitis B, influenza, herpes, AIDS and other diseases. Wherein the definition of each group in the general formula (I) is the same as that in the specification.
Morpholylureas are a new class of potent and selective inhibitors of the type 5 17-β-hydroxysteroid dehydrogenase (AKR1C3)
Flanagan, Jack U.,Atwell, Graham J.,Heinrich, Daniel M.,Brooke, Darby G.,Silva, Shevan,Rigoreau, Laurent J.M.,Trivier, Elisabeth,Turnbull, Andrew P.,Raynham, Tony,Jamieson, Stephen M.F.,Denny, William A.
, p. 967 - 977 (2014/02/14)
Inhibitors of the aldo-keto reductase enzyme AKR1C3 are of interest as potential drugs for leukemia and hormone-related cancers A series of non-carboxylate morpholino(phenylpiperazin-1-yl)methanones were prepared by palladium-catalysed coupling of substit